Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT05435846
Title Capmatinib Plus Trametinib for the Treatment of Metastatic Non-small Cell Lung Cancer With MET Exon 14 Skipping Mutation
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Collin Blakely

lung non-small cell carcinoma


Capmatinib + Trametinib

Age Groups: senior | adult
Covered Countries USA

Additional content available in CKB BOOST